Table 4 Results of colocalization analysis
From: Therapeutic Targets for Gastric Cancer: Mendelian Randomization and Colocalization Analysis
Exposure | Outcome | PP.H4.abf |
|---|---|---|
ANGPT2 | Gastric Cancer | 4.15% |
ATRAID1 | Gastric Cancer | 20.60% |
CD6 | Gastric Cancer | 2.11% |
CPQ | Gastric Cancer | 5.92% |
FUT8 | Gastric Cancer | 2.80% |
HCG22 | Gastric Cancer | 0.02% |
IGLC2 | Gastric Cancer | 2.37% |
LILRB1 | Gastric Cancer | 1.11% |
LTB | Gastric Cancer | 0.89% |
PPCDC | Gastric Cancer | 51.80% |
RGMA | Gastric Cancer | 3.70% |
TLR3 | Gastric Cancer | 0.95% |
TNFRSF10C | Gastric Cancer | 0.08% |
TNFRSF11A | Gastric Cancer | 0.27% |
TNFSF12 | Gastric Cancer | 5.69% |